TAIWAN-LISTED ETF
Fubon NYSE FactSet Global Genomics and Immuno Biopharma ETF
00897Public market and portfolio disclosure data. Latest market date: 2026-09-21.
Fund profile
| Issuer | Fubon Asset Management |
|---|---|
| Listing date | Oct 4, 2021 |
| Management fee | 0.85% |
| Custody fee | 0.20% |
| Total expense ratio | — |
| Beneficiaries | 10,073 |
| NAV | TWD 13.31 |
| Premium / discount | 0.38% |
Latest distribution
No data is currently available.
Sector allocation
No data is currently available.
Top 10 holdings
| Security | Portfolio weight |
|---|---|
| MRNA US · MODERNA INC | 9.56% |
| TWST US · TWIST BIOSCIENCE CORP | 6.45% |
| GMAB DC · GENMAB A/S | 4.01% |
| BAYN GY · Bayer AG | 3.87% |
| RVMD US · REVOLUTION MEDICINES INC | 3.79% |
| INCY US · INCYTE CORP | 3.58% |
| 4502 JP · Takeda Pharmaceutical Co Ltd | 3.57% |
| REGN US · REGENERON PHARMACEUTICALS INC | 3.57% |
| IOVA US · IOVANCE BIOTHERAPEUTICS INC | 3.50% |
| MRK US · MERCK & CO INC | 3.50% |
Compare 00897 with another Taiwan ETF
Compare fees, returns, risk and disclosed portfolio overlap.
Taiwan ETF overview FAQ
What information is available on a Taiwan ETF overview page?
The page combines price and premium history, fund size, beneficial owners, fees, distributions, leading holdings and sector allocation from public Taiwan market disclosures.
What does a portfolio weight mean?
A portfolio weight is the percentage of the ETF allocated to a security. Larger positions generally have a greater influence on the ETF’s net asset value.
How current are the figures?
Market, holdings and distribution data update on different schedules. Use the date displayed in each section rather than assuming every figure has the same effective date.
Data note
Prices, portfolio holdings, fund statistics and distributions may have different effective dates. Data is for research and reference only and is not investment advice.